BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32402473)

  • 1. The importance of Epstein-Barr virus infection in the systemic treatment of patients with gastric cancer.
    Pikuła A; Kwietniewska M; Rawicz-Pruszyński K; Ciseł B; Skórzewska M; Gęca K; Franciszkiewicz-Pietrzak K; Kurylcio A; Mielko J; Polkowski WP
    Semin Oncol; 2020; 47(2-3):127-137. PubMed ID: 32402473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer.
    Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM
    Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
    Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
    J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy.
    Pereira MA; Batista DAM; Ramos MFKP; Cardili L; Ribeiro RRE; Dias AR; Zilberstein B; Ribeiro U; Cecconello I; Alves VAF; Mello ES
    J Surg Res; 2021 May; 261():130-138. PubMed ID: 33429221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.
    Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG
    Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms.
    Cheng N; Hui DY; Liu Y; Zhang NN; Jiang Y; Han J; Li HG; Ding YG; Du H; Chen JN; Shao CK
    Gastric Cancer; 2015 Apr; 18(2):246-55. PubMed ID: 24771002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
    Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
    Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Yang J; Liu Z; Zeng B; Hu G; Gan R
    Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
    Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK
    Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
    Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
    Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
    Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
    Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
    Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
    Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Epstein-Barr virus and gastric cancer (review).
    Shinozaki-Ushiku A; Kunita A; Fukayama M
    Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.
    Murphy G; Pfeiffer R; Camargo MC; Rabkin CS
    Gastroenterology; 2009 Sep; 137(3):824-33. PubMed ID: 19445939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
    Sundar R; Qamra A; Tan ALK; Zhang S; Ng CCY; Teh BT; Lee J; Kim KM; Tan P
    Gastric Cancer; 2018 Nov; 21(6):1064-1070. PubMed ID: 29915957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
    Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
    World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
    Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
    J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.
    Chen JN; He D; Tang F; Shao CK
    J Clin Gastroenterol; 2012 Apr; 46(4):262-71. PubMed ID: 22392024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.